Answers are grounded in this paper and cite their sources.
Retrospective analysis finds full-dose adjuvant therapy critical for improved survival in gastric cancer, suggesting further study is needed.
Reduced-dose ACT after NACT and surgery was associated with inferior DFS and OS, indicating that maintaining full-dose adjuvant therapy is critical. These findings are limited by retrospective design; prospective response-adapted trials are needed.
No takes yet. Share an insight, caveat, or question.
Kaya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: